This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fabrizi F and Martin P (2001) Hepatitis B vaccine and dialysis: current issues. Int J Artif Organs 24: 683–694
Centers for Disease Control and Prevention (2001) Recommendations for preventing transmission of infectious diseases among chronic hemodialysis patients. MMWR Recomm Rep 50: 1–43
Verkade MA et al. (2004) Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients. Kidney Int 66: 614–621
Roozbeh J et al. (2005) Low dose intradermal versus high dose intramuscular hepatitis B vaccination in patients on chronic hemodialysis. ASAIO J 51: 242–245
Oddone EZ et al. (1993) A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients. Health Serv Res 28: 97–121
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Fabrizi, F., Martin, P. A new single-dose hepatitis B vaccine versus a conventional vaccine in patients with end-stage renal disease. Nat Rev Nephrol 2, 356–357 (2006). https://doi.org/10.1038/ncpneph0215
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0215